Business

Market Movers

CVS earnings climb more than 12 percent

Better pricing on generic drugs helped CVS raise its forecast for the near term.

Associated Press/File 2009

Better pricing on generic drugs helped CVS raise its forecast for the near term.

Advertisement

CVS Caremark shares outpaced the market after the drugstore chain raised its earnings forecast and reassured investors its business can absorb the hit from last week’s decision to stop selling tobacco: a $2 billion annual revenue loss and earnings 6 to 9 cents lower per share this year. CVS said fourth-quarter earnings climbed more than 12 percent to $1.27 billion, or $1.05 per share. Revenue rose nearly 5 percent to $32.83 billion. CVS raised its forecast for first-quarter earnings to $1.03 to $1.06 per share, up from 96 to 99 cents.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com